LRP6 and prostate carcinoma: Lu et al. (2014[25]) demonstrated that rottlerin induced Wnt co-receptor LRP6 degradation and suppressed both Wnt/β-catenin and mTORC1 signaling pathways in prostate cancer cells PC-3 and DU145.